Edwards Lifesciences (Brazil) Price Prediction
| E1WL34 Stock | 103.08 0.88 0.86% |
Oversold Vs Overbought
40
Oversold | Overbought |
Using Edwards Lifesciences hype-based prediction, you can estimate the value of Edwards Lifesciences from the perspective of Edwards Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Edwards Lifesciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Edwards because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Edwards Lifesciences after-hype prediction price | BRL 103.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Edwards |
Edwards Lifesciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Edwards Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Edwards Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Edwards Lifesciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Edwards Lifesciences Estimiated After-Hype Price Volatility
In the context of predicting Edwards Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Edwards Lifesciences' historical news coverage. Edwards Lifesciences' after-hype downside and upside margins for the prediction period are 101.16 and 105.00, respectively. We have considered Edwards Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Edwards Lifesciences is very steady at this time. Analysis and calculation of next after-hype price of Edwards Lifesciences is based on 3 months time horizon.
Edwards Lifesciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Edwards Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Edwards Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Edwards Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 1.92 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
103.08 | 103.08 | 0.00 |
|
Edwards Lifesciences Hype Timeline
Edwards Lifesciences is currently traded for 103.08on Sao Paulo Exchange of Brazil. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Edwards is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.15%. %. The volatility of related hype on Edwards Lifesciences is about 0.0%, with the expected price after the next announcement by competition of 103.08. The company has price-to-book (P/B) ratio of 1.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. Edwards Lifesciences has Price/Earnings To Growth (PEG) ratio of 0.77. The entity recorded earning per share (EPS) of 12.51. The firm had not issued any dividends in recent years. Edwards Lifesciences had 3:1 split on the 1st of June 2020. Assuming the 90 days trading horizon the next anticipated press release will be in a few days. Check out Edwards Lifesciences Basic Forecasting Models to cross-verify your projections.Edwards Lifesciences Related Hype Analysis
Having access to credible news sources related to Edwards Lifesciences' direct competition is more important than ever and may enhance your ability to predict Edwards Lifesciences' future price movements. Getting to know how Edwards Lifesciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Edwards Lifesciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| USSX34 | United States Steel | 0.00 | 0 per month | 4.27 | 0.02 | 6.57 | (3.70) | 27.79 | |
| SSFO34 | salesforce inc | 0.00 | 0 per month | 1.07 | 0.19 | 4.07 | (2.04) | 11.21 | |
| P2LN34 | Planet Fitness | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| S1PO34 | Spotify Technology SA | 0.00 | 0 per month | 2.20 | 0.19 | 3.11 | (3.56) | 18.04 | |
| BROF11 | Brpr Corporate Offices | 0.00 | 0 per month | 0.94 | (0.09) | 2.13 | (1.72) | 5.96 | |
| P2LT34 | Palantir Technologies | 0.00 | 0 per month | 1.52 | 0.27 | 6.79 | (3.44) | 25.10 | |
| TECN3 | Technos SA | 0.00 | 0 per month | 0.00 | (0.06) | 6.13 | (3.91) | 13.33 | |
| A1GI34 | Agilent Technologies | 0.00 | 0 per month | 0.00 | 0 | 2.20 | 0.00 | 15.21 |
Edwards Lifesciences Additional Predictive Modules
Most predictive techniques to examine Edwards price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Edwards using various technical indicators. When you analyze Edwards charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Edwards Lifesciences Predictive Indicators
The successful prediction of Edwards Lifesciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Edwards Lifesciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Edwards Lifesciences based on analysis of Edwards Lifesciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Edwards Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Edwards Lifesciences's related companies.
Story Coverage note for Edwards Lifesciences
The number of cover stories for Edwards Lifesciences depends on current market conditions and Edwards Lifesciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Edwards Lifesciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Edwards Lifesciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Edwards Lifesciences Short Properties
Edwards Lifesciences' future price predictability will typically decrease when Edwards Lifesciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Edwards Lifesciences often depends not only on the future outlook of the potential Edwards Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edwards Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 624.1 M |
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |